Table II.
Day hospital treatments in 2019 compared with those in 2020
| Variable | 2019 | 2020 | P values |
|---|---|---|---|
| Treatment days | 5.100 | 4.782 | <.05∗ |
| Total, N | 876 | 688 | <.001∗ |
| Male, n (%) | 427 (48.7) | 324 (47.1) | >.99 |
| Female, n (%) | 449 (51.3) | 362 (52.6) | >.99 |
| Age, mean (SD), in years | 46.85 (22.75) | 48.71 (22.68) | .975 |
| Stratified by age (years), n (%) | |||
| 0-17 | 115 (13.1) | 73 (10.6) | |
| 18-35 | 157 (17.9) | 140 (20.3) | |
| 36-49 | 142 (16.2) | 104 (15.1) | |
| 50-64 | 243 (27.7) | 172 (25.0) | |
| 65-74 | 122 (13.9) | 108 (15.7) | |
| 75-84 | 84 (9.6) | 76 (11.0) | |
| 85-94 | 9 (1.0) | 13 (1.9) | |
| 95+ | 4 (0.5) | 2 (0.3) | |
| <65 vs ≥65 | 219 (25.0) | 199 (28.9) | .923 |
| Disease classification (ICD-10), n (%) | |||
| Eczema, dermatitis, prurigo (L20, L28, L30) | 194 (22.1) | 170 (24.7) | >.99 |
| Psoriasis (L40) | 140 (16.0) | 104 (15.1) | >.99 |
| Epidermolysis bullosa (Q81) | 126 (14.4) | 86 (12.5) | >.99 |
| Lichen planus (L43) | 5 (0.6) | 8 (1.2) | >.99 |
| Cutaneous T-cell lymphoma (C84) | 6 (0.7) | 8 (1.2) | >.99 |
| Pemphigus foliaceus (L10) | 1 (<1) | 1 (<1) | >.99 |
| Bullous pemphigoid (L12) | 6 (0.7) | 9 (1.3) | >.99 |
Statistical analysis was performed with R (version 4.0.4). Categorical variables were tested with the chi-square test, continuous variables with a t test. The Holm method was used for the P value adjustment.
∗
Level of significance P < .05